Characterization of the neuroprotective effect of the cannabinoid agonist WIN-55212 in an in vitro model of hypoxic-ischemic brain damage in newborn rats.                                                      (abst – 2006)


Synergistic neuroprotective therapies with hypothermia.                   (full – 2010)


The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic- ischemic brain damage in mice is mediated by CB(2) and adenosine receptors. (abst – 2010)


The cannabinoid WIN55212-2 promotes neural repair after neonatal hypoxia-ischemia. (abst – 2010)                                 


Cannabidiol reduces brain damage and improves functional recovery after acute hypoxia- ischemia in newborn pigs.                                                              (abst – 2011)


The Cannabinoid WIN 55212-2 Mitigates Apoptosis and Mitochondrial Dysfunction After Hypoxia Ischemia.                                                           (abst – 2011)


Cannabinoid as a neuroprotective strategy in perinatal hypoxic-ischemic injury. (abst – 2011)                                               


Therapeutic potential of the endocannabinoid system in perinatal asphyxia (abst – 2011)                                 


Endocannabinoids reduce cerebral damage after hypoxic-ischemic injury in perinatal rats. (abst – 2012)                               

Share a link for